ACM
VRCA icon

Altium Capital Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Altium Capital Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,789
Closed -$794K – 141
2022
Q1 		$794K Hold
9,789
– – 0.27% 87
2021
Q4 		$897K Sell
9,789
-15,835
-62% -$1.79M 0.25% 98
2021
Q3 		$3.2M Sell
25,624
-26,889
-51% -$3.02M 0.84% 51
2021
Q2 		$5.93M Sell
52,513
-3,782
-7% -$458K 1.38% 16
2021
Q1 		$8.53M Buy
56,295
+45,416
+417% +$6.28M 2.37% 2
2020
Q4 		$1.25M Buy
+10,879
New +$1,000K 0.47% 78

Other funds holding VRCA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Altium Capital Management's VRCA Position: Q2 2022 in Review

Altium Capital Management sold out of Verrica Pharmaceuticals (VRCA) in Q2 2022, closing a stake of 9,789 shares — an estimated $794K sold.

Altium Capital Management first reported a position in VRCA in Q4 2020 and held it in 6 quarters. The position peaked at $8.53M in Q1 2021. 57 funds tracked by Wall St. Rank hold VRCA as of Q2 2022.

  • Altium Capital Management reported no remaining Verrica Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Altium Capital Management sold 9,789 Verrica Pharmaceuticals shares in Q2 2022, an estimated $794K.
  • Altium Capital Management first reported a position in Verrica Pharmaceuticals in Q4 2020 and held it in 6 quarters.
  • Altium Capital Management's Verrica Pharmaceuticals position peaked at $8.53M in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2022.

Based on Altium Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.